Showing 1431-1440 of 8825 results for "".
Noah Worcester 2024: Dr. Adams on Sports Dermatology
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-adams-sports-dermatology/24584/Brian Adams, MD, MPH, summarizes his lecture on treating professional athletes at the 2024 Noah Worcester Dermatological Society meeting.DermWireTV: Novan EPI Acquisition, Champions for Change Gala, Mt. Sinai Alopecia Center
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-novan-epi-acquisition-champions-for-change-gala-mt-sinai-alopecia-center/20070/EPI Health is now a Novan company; the combined company will employ approximately 100 staff. Novan’s lead candidate, berdazimer gel 10.3%, performed well in a phase 3 study for the treatment of molluscum contagiosum. The Skin Cancer Foundation is gearing up for its signature fundraising event: The CThe Easy Es of Managing Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/the-easy-es-of-managing-eczema/19978/Atopic dermatitis can have a profound effect on patients' lives—from associated comorbidities to sleep issues and more. Adam Friedman, MD says it’s essential to Educate patients regarding good skin care, manage Expectations, provide Enough appropriate medication, End misdiagnoses, and Engage assistaWhy you need to update your Google My Business profile
https://practicaldermatology.com/topics/practice-management/why-you-need-to-update-your-google-my-business-profile/19911/Google My Business has some very interesting new and upcoming features. Watch this short video from Ekwa Marketing to learn what they are and how you can put them to work for your dermatology practice.What to Know About Sunscreens and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-to-know-about-sunscreens-and-more/19888/Henry Lim, MD summarizes a presentation from San Diego Dermatology Symposium, offering updates on sunscreen labeling and more.Content marketing in the age of COVID 19
https://practicaldermatology.com/topics/practice-management/content-marketing-in-the-age-of-covid-19/19836/COVID-19 has changed everything, probably including the way you promote your practice. Content marketing has become more challenging, and more important than ever. Check out this short video from Ekwa Marketing to learn what to do (and what not to do) for a successful content marketing strategy.Improving Mastectomy Scars with the Vbeam Prima
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-mastectomy-scars-with-the-vbeam-prima/19692/Many women with breast cancer will undergo a mastectomy, resulting in major scarring on the breasts. Jill Waibel, MD is passionate about helping these women get the treatment they deserve post-surgery and uses the Vbeam Prima, a pulsed dye laser device, to help improve the appearance of the scars. WA Specialty in Transition
https://practicaldermatology.com/topics/practice-management/a-specialty-in-transition/18343/Dermatology's past is impressive, but it's future is even more promising. In this final episode of our docu-series, hear how dermatologists are taking the lead in advocating for the specialty—and patients.2017 Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/2017-tax-cuts-and-jobs-act-what-you-need-to-know--vmyiwowa/18348/OJM Group principal Carole Foos, CPA provides an overview of the Tax Cuts and Jobs Act, which was signed in to law at the end of 2017. She discusses key provisions affecting individual physicians and medical practices, and offers advice to consider when planning for 2018 and beyond. Click here to reAllergan Acquires Vitae, PsA Day, Novan News
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-allergan-acquires-vitae-psa-day-novan-news/18572/Allergan is acquiring clinical-stage biotechnology company Vitae Pharmaceuticals for $21.00 per share, in cash, for a total transaction value of approximately $639 million. Novan has launched its initial public offering and is now listed on the NASDAQ. Celgene Corporation and the National Psoriasis